SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis
SETD2, a H3K36 trimethyltransferase, is the most frequently mutated epigenetic modifier in lung adenocarcinoma, with a mutation frequency of approximately 9%. However, how SETD2 loss of function promotes tumorigenesis remains unclear. Using conditional Setd2-KO mice, we demonstrated that Setd2 defic...
Main Authors: | Yuchen Xie, Merve Sahin, Toru Wakamatsu, Akane Inoue-Yamauchi, Wanming Zhao, Song Han, Amrita M. Nargund, Shaoyuan Yang, Yang Lyu, James J. Hsieh, Christina S. Leslie, Emily H. Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2023-02-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.154120 |
Similar Items
-
SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells
by: Jianxu Chen, et al.
Published: (2023-09-01) -
PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis
by: Liwen Li, et al.
Published: (2021-03-01) -
A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
by: Hira Javaid, et al.
Published: (2023-08-01) -
An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment
by: Bing Yang, et al.
Published: (2022-03-01) -
Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML
by: Zuzana Tothova, et al.
Published: (2021-02-01)